NEW YORK (GenomeWeb News) – Dutch molecular diagnostics company GenDx announced today that Qiagen has granted it non-exclusive rights for the worldwide distribution for Qiagen's LongRange PCR kit in combination with GenDx's SBTexcellerator reagents for high-resolution HLA typing.

The agreement covers both direct distribution by GenDx as well as third-party distribution.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.